What did we learn from the bictegravir switch studies?

被引:9
|
作者
Harris, Marianne [1 ]
机构
[1] British Columbia Ctr Excellence HIV AIDS, Vancouver, BC V6Z 1Y6, Canada
来源
LANCET HIV | 2018年 / 5卷 / 07期
关键词
NON-INFERIORITY TRIAL; TENOFOVIR ALAFENAMIDE; INITIAL TREATMENT; DOUBLE-BLIND; EMTRICITABINE; DOLUTEGRAVIR; MULTICENTER; INHIBITORS; PHASE-3;
D O I
10.1016/S2352-3018(18)30099-7
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
引用
收藏
页码:E336 / E337
页数:2
相关论文
共 50 条
  • [41] What did we learn from neural grafts in Huntington disease
    Bachoud-Levi, A. -C.
    REVUE NEUROLOGIQUE, 2022, 178 (05) : 441 - 449
  • [42] Film Cooling: What did we learn from our measurements?
    Arts, T
    HEAT TRANSFER IN GAS TURBINE SYSTEMS, 2001, 934 : 126 - 134
  • [43] Fertility and partnership: Why the FFS and what did we learn from it?
    Macura, M
    Beets, G
    Burkimsher, M
    Dynamics of Fertility and Partnership in Europe: Insights and lessons from Comparative Research Vol 1, 2002, : 1 - 12
  • [44] THE ORIGIN OF THE MOON - WHAT DID WE LEARN FROM SPACE MISSIONS
    LANGEVIN, Y
    BULLETIN DE LA SOCIETE GEOLOGIQUE DE FRANCE, 1987, 3 (01): : 65 - 69
  • [45] What did we learn from the New England Journal of Medicine?
    Parmley, WW
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2000, 35 (01) : 254 - 254
  • [46] The regulation of genomics: What did we learn from the GMO story?
    Adcock, M
    Kinderlerer, J
    GENOMICS FOR BIOSAFETY IN PLANT BIOTECHNOLOGY, 2004, 359 : 233 - 246
  • [47] What did we learn from new oral anticoagulant treatment?
    Esmon, Charles T.
    THROMBOSIS RESEARCH, 2012, 130 : S41 - S43
  • [48] What did we learn from animal models in peritoneal dialysis?
    Lameire, Norbert
    Van Biesen, Wim
    Mortier, Siska
    DeVriese, An
    PERITONEAL DIALYSIS: A CLINICAL UPDATE, 2006, 150 : 70 - 76
  • [49] THE PSYCHENCODE CONSORTIUM: WHAT DID WE LEARN AND WHAT IS NEXT?
    Roussos, Panos
    Ahituv, Nadav
    Geschwind, Daniel
    EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2019, 29 : S45 - S46